Tokyo and Basking Ridge, NJ – (June 18, 2025) – The first patient has been dosed in the IDeateProstate01 phase 3 trial evaluating the...
Vous n'êtes pas connecté
- THEINDIANSUN.COM.AU - A La Une - 14/Jan 02:56
Levofloxacin: A new shield against drug-resistant TB
The fight against drug-resistant tuberculosis (TB) has taken a significant leap forward with recent findings from a clinical trial involving the oral antibiotic levofloxacin. Conducted by researchers at the University of Sydney’s Woolcock Institute of Medical Research in collaboration with the Vietnam Tuberculosis Program, the trial has demonstrated the efficacy and safety of levofloxacin in […]
Articles similaires
Australian-led breakthrough in stem cell transplant for blood cancers set to change 40 years of standard practice
oncologynews.com.au - 23/Jun 18:46
Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for leukaemia significantly...
Once-monthly obesity injection shows double-digit weight loss in major clinical trial
news.medical.net - 25/Jun 02:29
Researchers found that once-monthly maridebart cafraglutide led to substantial weight loss and improved glycemic control in adults with obesity, with...
Ending TB In Southeast Asia: ASEAN's Vaccine Diplomacy And Digital Health Tools
wn.com - 24/Jun 18:02
(MENAFN - The Conversation) Association of Southeast Asian Nations (ASEAN) has consistently taken a proactive role in controlling tuberculosis (TB) in...
Ending TB In Southeast Asia: ASEAN's Vaccine Diplomacy And Digital Health Tools
wn.com - 24/Jun 18:02
(MENAFN - The Conversation) Association of Southeast Asian Nations (ASEAN) has consistently taken a proactive role in controlling tuberculosis (TB) in...
Harnessing India’s medical colleges in the fight against TB
wn.com - 24/Jun 08:08
India has made undeniable progress in its battle against tuberculosis (TB). The World Health Organization (WHO) acknowledged a 17.7% drop in TB...
Harnessing India’s medical colleges in the fight against TB
wn.com - 24/Jun 08:08
India has made undeniable progress in its battle against tuberculosis (TB). The World Health Organization (WHO) acknowledged a 17.7% drop in TB...
Aspire Biopharma enrolls last patient in phase 1 trial of its oral transmucosal fast─acting high─dose aspirin formulation
pharmabiz.com - 26/Jun 14:53
Aspire Biopharma Holdings, Inc, developer of a multi─faceted patent─pending drug delivery technology, announced the last patient was dosed in its...
Latest releases
-
Aucun élément